Skin Penetration and Depot Formation An ex vivo human skin penetration study measured a permeability coefficient of 2.43 x 10^-4 cm/h for copper tripeptide, with 82 micrograms per square centimeter retained in dermal tissue as a depot over 48 hours (PMID 20703511)
doi: 10.1021/acs.chemrev.7b00650 46 ReisRAGLiHJohnsonMSobradoP
Regulatory note: AOD-9604 is an unapproved research chemical , is not FDA-approved for human use, and its weight-loss efficacy in humans is unproven [3] [6]
Who Should Exercise Caution: Consult a healthcare provider before using BPC-157 if you have: Uncontrolled high blood pressure Currently take blood pressure medications History of stroke or cardiovascular events Bleeding disorders or use blood thinners Dosage and Side Effect Risk Higher doses correlate with increased side effect frequency, that relationship holds true for BPC-157, though the peptide has an unusually wide safety margin compared to most pharmaceutical compounds
What are the common side effects
Experiencing memory loss or dementia Issues with concentrating on tasks Persistent lowered mood or depression Mania extreme and uncharacteristically elevated moods Entering non-responsive states, or becoming catatonic Experiencing symptoms associated with schizophrenia Episodes of psychosis, delusions and delirium Other Conditions A variety of other conditions can also cause peripheral neuropathy
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
